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Original article
Diagnosis of pulmonary tuberculosis among asymptomatic HIV+
patients in Guangxi, China
ZHANG Yao, YU Lan, TANG Zhi-rong, HUANG Shao-biao, ZHENG Yuan-jia, MENG Zhi-hao,
SUN Kai, WANG Li-ming, Ray Y. CHEN and ZHANG Fu-jie
Keywords: tuberculosis; human immunodeficiency virus; diagnosis
Background Pulmonary tuberculosis (PTB) among asymptomatic Chinese patients with HIV infection has not been
investigated despite high tuberculosis burden in China. This study was aimed to evaluate the prevalence, risk factors and
clinical outcomes of PTB among asymptomatic patients with HIV/AIDS in Guangxi to facilitate the development of
diagnostic and treatment strategies.
Methods All asymptomatic adult HIV-infected patients with CD4 <350 cells/µl who attended four HIV clinics in Guangxi
between August 2006 and March 2008 were evaluated for active PTB with physical examination, chest X-ray (CXR),
sputum smear and/or sputum liquid culture. Data were described using median (interquartile range, IQR) and frequencies.
Univariate and multivariate Logistic regression analyses were performed to identify risk factors associated with PTB.
Results Among 340 asymptomatic subjects, 15 (4%) were diagnosed with PTB, with 4 (27%) sputum smear positive
and 8 (53%) sputum culture positive. CXR has higher diagnostic sensitivity (87%) than sputum smear (25%) and sputum
culture (67%), but lower specificity (56%) compared with sputum smear (99%) and culture (100%). In univariate analysis,
injection drug user, body mass index (BMI) <18 kg/m2, CD4 <50 cells/µl and presence of peripheral lymphadenopathy
were associated with an increased risk of asymptomatic PTB, while in multivariate analysis only peripheral
lymphadenopathy maintained statistical significance (OR=7.6, 95% CI 1.4–40). Patients with negative smear and minor
or no abnormalities on CXR had longer interval between screening and TB treatment.
Conclusions PTB was relatively common in this group of HIV+ asymptomatic Chinese patients. Diagnosis is
challenging especially where sputum culture is unavailable. These findings suggest that an enhanced evaluation for PTB
needs to be integrated with HIV care in China and transmission prevention in China to control at both households and
health care facilities, especially for patients with factors associated with a higher risk of PTB.
Chin Med J 2010;123(23):3400-3405

T

uberculosis (TB) is endemic in many developing
countries including China and is a major cause of
morbidity and mortality in people living with
HIV/AIDS.1-5 Both asymptomatic and subclinical
pulmonary TB (PTB) are relatively common among HIV+
patients in TB endemic areas, and undiagnosed TB is a
key cause of the immune reconstitution inflammatory
syndrome, but the most effective TB diagnostic strategy
in the developing country setting is not clear.6-9 The
World Health Organization (WHO) recommends sputum
smear microscopy in all HIV patients with clinical
features suggestive of PTB, with follow-up chest X-ray
(CXR) if sputum smear is negative,10 but this algorithm is
limited by poor sensitivity.11,12 In developed countries
like the United States, CXR, sputum smear and culture
are all included in the evaluation of suspected PTB.13
However, neither of these approaches addresses
asymptomatic persons. By definition, asymptomatic PTB
is a diagnosis based on positive radiologic and/or
microbiologic evidence with a negative symptom
screening, while the diagnosis of subclinical PTB is based
on positive culture and/or smear without any CXR or
symptom findings. Mtei et al8 reported that in Tanzania
the prevalence of subclinical TB and asymptomatic TB
were 4.3%, and 9.6%, respectively. A study from South
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India showed that 4% of asymptomatic HIV positive
individuals with normal chest radiograph and negative
sputum smears had positive sputum cultures for M.
tuberculosis.9 Among HIV-infected gold miners in South
Africa, PTB was diagnosed in 2.7% of asymptomatic
patients.7 Given the high background prevalence of
tuberculosis, Chinese guidelines suggest an annual CXR
and sputum smear examination in all HIV+ patients
regardless of symptoms, although this strategy has not
been compared with recommendations from other
countries.14
Assessing for PTB in asymptomatic HIV+ patients is of
public health and clinical importance because a missed
TB diagnosis is associated with adverse consequences
due to delayed or absent treatment.8,15 In addition,
initiating antiretroviral therapy (ART) with an
undiagnosed TB infection may result in rapid
deterioration due to TB-associated immune reconstruction
inflammatory syndrome, which is particularly important
during antiretroviral therapy scaling-up programs.16,17
Finally, without prompt treatment, the risk of household
and nosocomial transmission of TB is significantly
increased.
The purpose of this study is to evaluate the prevalence,
risk factors and clinical outcomes of PTB among
asymptomatic patients with HIV/AIDS in Guangxi, China
to facilitate the development of diagnostic and treatment
strategies.
METHODS
Study subjects and protocol
HIV positive patients at least 18 years old and receiving
routine HIV outpatient care at 4 sites (Nanning 4th
People’s Hospital, Longtan Hospital, Liuzhou CDC
Clinic, and Guangxi CDC Clinic) in Guangxi Zhuang
Autonomous Region from August 2006 to March 2008
were eligible for this study. After informed consent,
patients were administered a TB symptom questionnaire
regarding the presence and duration of cough, sputum
production, hemoptysis, dyspnea, chest pain, night sweats,
fatigue, fever and subjective weight loss in the past 6
months. Patients received CD4 count testing if not
performed within the previous two months. Symptomatic
patients were not included in this analysis. Patients
without any of the above symptoms and with CD4 count
less than 350 cells/µl were invited to undergo PTB
screening with a posterior-anterior CXR and acid-fast
bacilli (AFB) stain and liquid culture from up to 3 sputum
specimens. CXR was interpreted and described in detail
by radiologists at each study site. Attempts were made to
obtain three self-produced sputum samples for smear and
culture, one at the time of clinic visit, one in the evening,
and one upon first awakening in the morning. For patients
who received repeated TB screening at subsequent
follow-up visits, only the initial evaluation was included
in this analysis. Those diagnosed with PTB were

scheduled for standard follow up visits at 0.5, 1, 2, and 3
months after enrollment and once every 3 months
thereafter. This study was approved by the institutional
review board of the Chinese Centers for Disease Control
and Prevention.
Laboratory methods
Sputum was digested and decontaminated with
N-acetylcysteine and concentrated by centrifugation.
Ziehl-Neelson staining was used for sputum smear.
Culture was conducted in BacT/Alert MP liquid culture
media using the BacT/Alert 3D automated detection
system (BioMerieux, Marcy L’Etoile, France).
Mycobacterial speciation was conducted using gold
immunochromatography assay.
Case definitions
Patients were identified as having PTB if they had either:
(1) at least one positive sputum culture for M.
tuberculosis or positive sputum smear for AFB; or (2)
radiological features consistent with PTB infection, no
response to 5 days of broad spectrum antibiotics, and
improvement after empiric TB treatment. Patients
suspected of concomitant extrapulmonary TB infection
were administered additional testing as clinically
indicated, and culture, AFB smear and pathology studies
were performed on relevant specimen samples. When
microbiologic or pathologic studies were negative and
extrapulmonary TB was still suspected, empiric diagnosis
was made by the failure to respond to broad spectrum
antibiotics and subsequent improvement on TB specific
therapy.
Statistical analysis
Medians (interquartile range, IQR) and frequencies (%)
were used to describe the patient characteristics.
Categorical variables were compared using chi-square or
Fisher’s exact tests as indicated. Continuous variables
were compared using the Mann-Whitney U test. Analysis
of clinical and demographic factors associated with PTB
was performed for all patients who underwent all three
examinations (CXR, sputum smear and culture) to avoid
bias associated with the likelihood of performing a test.
Factors considered clinically relevant and associated with
PTB diagnosis in univariate Logistic regression (P <0.10)
were included in the multivariate model. A two-side P
value <0.05 was considered statistically significant.
Statistical analyses were performed using STATA
(Version 9.1, College Station, TX. USA).
RESULTS
Between August 2006 and Decbmer 2008, 514 asymptomatic HIV-infected individuals were identified based on
negative symptom questionnaires. Of these, 18 patients
with known active PTB undergoing treatment at the time
of enrollment were excluded. Among the remaining, 359
had CD4 count less than 350 cells/µl and were invited for
further PTB evaluation with CXR, sputum smear
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Table 1. Characteristics of 15 asymptomatic HIV-infected subjects with PTB

Patients

CD4 cell count On BMI
Lymph(cells/µl)
ART (kg/m2) adenopathy

1

204

Yes

17.1

−

2
3
4
5
6
7
8

180
114
27
249
8
14
280

No
Yes
Yes
Yes
Yes
No
No

22.2
21.7
17.4
22.1
16.6
17.9
19.1

9

56

Yes

21.1

+
+
+
−
+
+
−
−

10
11
12
13
14
15

16
12
10
229
2
26

Yes
Yes
Yes
No
Yes
Yes

17.9
17.6
20.1
13.8
18.4
20.6

−
−
−
−
−
−

Chest X-ray

Sputum
smear

Sputum Interval from screening Extrapulmonary Survival after 1 year
culture
to treatment (days)
TB
from screening
−
+
89
No

Upper lobe infiltrates,
+
increased lung markings
Lower lobe infiltrates
+
+
14
Increased lung markings
−
+
3
Increased lung markings
Nil
Nil
91
Right lower lobe infiltrates
Nil
Nil
36
Right lower lobe infiltrates
−
−
30
Left lower lobe infiltrates
−
−
1
No abnormalities
−
+
105
Right middle lobe infiltrate,
+
Nil
1
hilar lymphadenopathy
No abnormalities
+
+
58
Left side pleural effusion
−
−
1
Increased lung markings
−
+
Died before Tx
Increased lung markings
−
+
Died before Tx
Increased lung markings
−
+
174
Bilateral scattered infiltrates
−
−
17
Patients 3 and 7 died before TB treatment. Tx: treatment.

and sputum culture. Nineteen patients declined to join the
study, leaving 340 participants. All but one patient had
CXR results. Although 156 (46%) and 130 (38%)
individuals provided sputum specimens for AFB smear
and sputum culture, respectively, only 128 (38%) had
both, and 127 (37%) had all three recommended
examinations.
Among the 340 included patients, active PTB was
diagnosed in 15 (4%) patients (Table 1), of which 8 (53%)
had positive sputum cultures, 4 (27%) had positive AFB
smears, and 6 were diagnosed solely based on clinical
features. The median age was 32 years (range 26–56), 9
(67%) were male, and median CD4 count at screening
was 27 cells/µl (range 2–280 cells/µl). Five patients
diagnosed with PTB had peripheral lymphadenopathy,
among them three were diagnosed with TB lymphadenitis.
Other forms of extrapulmonary TB were found in this
study.
Among PTB cases, increased lung markings was the most
frequently reported radiographic abnormality (40%),
followed by lower lobe infiltrates (27%) and normal CXR
(13%). Upper lobe infiltrates and left sided pleural
effusion were each seen in one patient. No one was found
to have pulmonary cavitation. Among 8 patients with
normal or increased lung markings on CXR, 6 had
positive sputum cultures, but only 1 was smear-positive.
Among a total of 8 culture positive TB cases, only 3
(37%) were smear-positive. A total of 5 smear positive
cases were identified, with one (20%) later determined to
be a non-tuberculosis mycobacterium (NTM). Based on
the 127 patients who underwent all recommended
workups (CXR, sputum smear and sputum culture), the
sensitivity was 87% for any abnormal CXR, 67% for a
positive sputum culture, and 25% for a positive sputum
AFB smear. The specificities of an abnormal CXR and
positive sputum smear were 56% and 99%, respectively.
NTM was identified in 4 (3%) individuals with sputum
culture.

−
+
+
−
−
+
−
−

Yes
Yes
Yes
Yes
No
No
Yes

−
−
−
−
−
−

Yes
Loss
No
No
No
Yes

Yes

Among the 15 patients diagnosed with PTB in this study
at one year, 8 were still alive, 1 was lost to follow-up, and
6 had died, giving a one-year mortality rate of 40%. PTB
patients with normal CXR or only increased lung
markings and negative sputum smears experienced
significant delay between screening and treatment
(median 105 days), compared to patients with more
prominent CXR findings or positive sputum smear
(median 17 days, P=0.01). Two patients died before
treatment initiation, both of whom had negative sputum
smears and normal or increased lung markings on chest
radiography at screening. Given the limited sample size,
Logistic regression analysis for risk factors for mortality
was not performed.
Based on the 127 patients who had all three evaluations,
baseline demographic, laboratory and clinical characteristics were compared between those with and without PTB
(Table 2). In univariate analyses, injection drug use (IDU),
body mass index (BMI) <18 kg/m2, CD4 <50 cells/µl and
presence of peripheral lymphadenopathy were associated
with increased risk of asymptomatic PTB, while in
multivariate analyses only peripheral lymphadenopathy
maintained statistical significance (OR=7.8, 95% CI
1.4–42). Among 18 patients who had peripheral
lymphadenopathy, 5 (28%) had PTB, compared to 7 (3%)
among 322 participants without peripheral lymphadenopathy.
DISCUSSION
Symptomatic screening has been shown to be fairly
effective in ruling out TB. In the recent study by Cain et
al,12 a combination of three symptom predictors was 97%
effective in ruling out active TB. However, that still left
3% of patients in their study and 4% of patients in our
study who were asymptomatic but still had active TB. In
TB-endemic locales, this can still translate into a large
amount of morbidity and mortality, especially with
subsequent secondary infections. This finding highlights
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Table 2. Comparison of subjects with and without PTB

Subjects without PTB
Subjects with PTB
P values
OR (95% CI)
Characteristics
(n=115)
(n=12)
(univariate regression analysis)
(multivariate regression analysis)
Age (median (IQR), years)
35 (28–44)
36 (31–47)
0.850
NS
Male (n (%))
65 (57)
7 (58)
0.900
NS
Injection drug use (n (%))
33 (29)
7 (58)
0.040
NS
Contact history of TB (n (%))
2 (2)
0 (0)
*
NS
BMI <18 kg/m2 (n (%))
25 (22)
6 (50)
0.030
NS
Lymphadenopathy (n (%))
5 (4.3)
5 (42)
0.005
7.8 (1.4–42.0)
CD4 at screening <50 cells/µl (n (%))
32 (28)
7 (58)
0.045
NS
On ART (n (%))
98 (85)
8 (67)
0.100
NS
*
Not included in the analysis since only 2 subjects reported TB contact history. IQR: interquartile range. NS: no significance. PTB: pulmonary tuberculosis.

the importance of being vigilant when caring for HIV
infected patients in TB endemic areas, even when patients
are asymptomatic.
Identifying a test with appropriate sensitivity and
specificity to diagnose PTB among asymptomatic
HIV-infected individuals is difficult. Because our patients
were asymptomatic, sputum AFB smear was only 25%
sensitive, lower than previous estimates (31%–80%),6 but
99% specific. Because of this low sensitivity, sputum
culture is needed but even this was only 67% sensitive in
our study. Among all patients with positive sputum
culture, 4 yielded NTM and 8 M. tuberculosis, suggesting
that NTM infection or colonization is relatively common
in this study population.3 CXR had the highest sensitivity
(87%) in our study but lower specificity (56%) in
diagnosing PTB in our study compared with sputum
smear and culture. Typical CXR findings for PTB, such
as upper lobe infiltrate or cavitation, were present in only
one case. Thus, CXR alone as well was insufficient for
diagnosis in our study, consistent with previous
reports.18,19 Our data reinforce the concept that among
asymptomatic HIV+ patients, neither sputum smear or
CXR alone, nor their combination is sufficient for
diagnosing PTB.6 Sputum culture is still necessary to
improve diagnostic yield but the importance of clinical
vigilance and close follow-up cannot be overstated.
We identified several factors associated with active PTB
in the study population. Univariate analysis showed that
patients with a history of IDU, BMI <18 kg/m2, and CD4
<50 cells/µl were more likely to be diagnosed with PTB,
consistent with risk factors from other studies.20-24
Peripheral lymphadenopathy was also associated with
higher risk for PTB and remained the only statistically
significant risk factor in the multivariate analysis. The
association with IDU compared to other exposure groups
(mostly heterosexual transmission) is likely due to a
higher background prevalence of latent TB infection and
social or lifestyle factors resulting in more frequent
exposure. Consistent with finding of a previous study,8
our participants with peripheral lymphadenopathy had
close to an 8-fold higher risk for PTB. Since TB is a
major cause of enlarged lymph nodes in HIV infected
populations in developing countries,25,26 we speculate that
this association is mainly attributable to a common
etiology for pulmonary and lymph node involvement.
This finding helps us identify a sub-group of higher risk

patients on whom to focus intervention efforts.
Notably, 40% (6/15) of these asymptomatic PTB patients
died within one year of enrollment. Studies have shown
that multiple factors contribute to high mortality among
patients with HIV/TB co-infection, including delayed TB
diagnosis and treatment, infection with drug resistant TB,
delayed
or
absent
ARV
therapy,
advanced
immunosuppression and certain baseline demographic
characteristics.27-31 Our study was unfortunately not
powered to investigate the role of individual factors. We
do show, however, that without an abnormal CXR or AFB
positive sputum smear, TB diagnosis and treatment was
significantly delayed or totally absent among these
asymptomatic patients. Among the 5 patients with an
AFB negative sputum smear but subsequent positive
sputum culture, 2 (40%) died before TB treatment was
initiated.
Overall, we found a 4.4% prevalence of PTB among
asymptomatic HIV+ Chinese patients with advanced
immunosuppression (CD4 <350 cells/µl), and 67% of the
cases were culture positive. The relatively high
prevalence of PTB in asymptomatic HIV+ patients found
in this study has several implications that are in line with
the WHO recommendations regarding TB control. First, it
reinforces the idea that in TB endemic areas even among
asymptomatic patients, intensified case finding of TB
should be prioritized in HIV+ people with CD4 <350
cells/µl. This heightened vigilance is particularly relevant
to the recommended roll-out of INH preventive treatment
among HIV infected patients in TB endemic settings,10 as
INH monotherapy may induce resistance in patients with
active TB. Second, symptom-based diagnostic
approaches will miss a number of PTB cases among
HIV+ patients with advanced immunodeficiency.
However, until simpler, cheaper and more accurate
diagnostics are developed and validated, we will still rely
on the combination of available radiological and
microbiological tests and clinical judgment, especially
before initiating antiretroviral therapy. Providers in rural
healthcare settings should familiarize themselves with the
strengths and shortcomings of these available tools so as
to use them properly. Third, strategies must be
implemented to prevent TB transmission within
households and healthcare settings. In this study, 53% of
diagnosed PTB cases were sputum culture positive and
33% sputum smear positive, while the median interval
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from screening to treatment was prolonged at 4 weeks,
conferring considerable risk of transmission. Well
established and simple methods of infection control
including patient education, frequent ventilation, case
isolation and using reliable protective masks are
paramount and should be appropriately utilized.
There are several limitations to our work. First, the
overall prevalence of PTB was likely underestimated in
our study because 46% of participants declined to provide
sputum specimens for smear and culture and, among
those who provided sputum samples, only 37% provided
three. This underestimation, although further underpowering our study to find relevant risk factors, does not
change the result that we did find of lymphadenopathy
being significantly associated with PTB. Had this study
been less under-powered, we may have been able to
identify more risk factors. Second, the locations of
involved lymph nodes were not recorded in this study, so
we were not able to distinguish generalized from
localized lymphadenopathy. While localized lymph node
enlargement is frequently caused by TB and associated
with
pulmonary
involvement,
generalized
lymphadenopathy is more likely to be related to the HIV
infection itself. Lastly, tuberculin skin testing (TST) was
not performed in this study, so we could not evaluate the
diagnostic value of this widely available test. Studies
have demonstrated that tuberculin positivity is related to
active TB,32,33 and thus can be used to further stratify risk
groups for PTB.

4.

5.

6.

7.

8.

9.

10.

11.

The intersecting epidemics of TB and HIV present a
serious public health problem in China. Liquid sputum
culture is currently the gold standard for TB diagnosis.
However, the cost, long cultivation period and associated
delay of treatment all hinder its use in resource limited
settings such as rural China, which truly emphasizes the
need for more rapid and available diagnostic tools. Given
the serious consequences of undiagnosed TB, we propose
that extended evaluation for PTB should be performed
among asymptomatic Chinese patients with HIV
prioritizing those with relevant risk factors, such as
peripheral lymphadenopathy. Larger studies need to be
done to identify additional risk factors among this cohort
that can help identify those at the highest risk of active
TB infection. Subsequent prevention of secondary
transmission at the levels of the households and health
care facilities can then also be applied.
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